Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 609
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01347034 | Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) | ||
| NCT06423963 | Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer | ||
| NCT02139358 | Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer | ||
| NCT05378464 | Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer | ||
| NCT01657591 | Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT01432574 | Study of Gardasil in Mid-Adult Males (MAM) | ||
| NCT05083416 | Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome | ||
| NCT04596579 | SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida | ||
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | ||
| NCT02440425 | Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer | ||
| NCT01400958 | Nuvigil or Placebo in Newly Diagnosed Malignant Glioma | ||
| NCT00313508 | Dendritic Cell Vaccination During Lymphoid Reconstruction | ||
| NCT02466568 | Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung | ||
| NCT05664178 | Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology | ||
| NCT00738751 | Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers | ||
| NCT06833502 | Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer | ||
| NCT01681875 | Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes | ||
| NCT03337451 | Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome | ||
| NCT06597565 | A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC | ||
| NCT02776709 | Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass) | ||
| NCT02945800 | Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma | ||
| NCT03663166 | Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT00694551 | PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment | ||
| NCT03630809 | Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 | ||
| NCT07014605 | Smoking Cessation Program for Lao People With HIV | ||
| NCT01352000 | Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline") | ||
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | ||
| NCT02803333 | Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study | ||
| NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | ||
| NCT00815750 | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients | ||
| NCT06219174 | Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) | ||
| NCT05362318 | Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free | ||
| NCT06691035 | Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer | ||
| NCT03370276 | Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | ||
| NCT00948922 | Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | ||
| NCT02891603 | A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression | ||
| NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
| NCT05065944 | Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center | ||
| NCT00480584 | A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | ||
| NCT00323206 | Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma | ||
| NCT05064423 | Clinical Trials Outreach & Education | ||
| NCT00216008 | Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. | ||
| NCT03183050 | MEND 2: Making Treatment Decisions Using Genomic Testing | ||
| NCT03177291 | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | ||
| NCT02978443 | A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab | ||
| NCT01951976 | Yoga for Aromatase Inhibitor-associated Joint Pain | ||
| NCT03870399 | Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | ||
| NCT06483139 | Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy | ||
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL | ||
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide |
